Streetbeat News

Price Targets

BLNK

HC Wainwright & Co. analyst Sameer Joshi has maintained a Buy rating on Blink Charging (NASDAQ:BLNK) but has reduced the price target from $50 to $25.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:28 pm

DOCS

Piper Sandler analyst Jessica Tassan has maintained a Neutral rating on Doximity (NYSE:DOCS) and increased the price target from $21 to $23.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:24 pm

OTLY

Piper Sandler analyst Michael Lavery has maintained an Overweight rating on Oatly Group (NASDAQ:OTLY) but reduced the price target from $3 to $2, as reported on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:23 pm

XERS

Piper Sandler analyst David Amsellem has maintained an Overweight rating on Xeris Biopharma Holdings (NASDAQ:XERS) but reduced the price target from $5 to $4. The report was released on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:21 pm

XERS

Piper Sandler analyst David Amsellem has maintained an Overweight rating on Xeris Biopharma Holdings (NASDAQ:XERS) but reduced the price target from $5 to $4.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:21 pm

EDAP

Piper Sandler analyst Jason Bednar has maintained an Overweight rating on Edap TMS (NASDAQ:EDAP) but reduced the price target from $14 to $9. The report was released on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:18 pm

HUMA

Piper Sandler analyst Matt O'Brien has maintained a Neutral rating on Humacyte (NASDAQ:HUMA) but reduced the price target from $3.5 to $3, as reported on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:16 pm

HUMA

Piper Sandler analyst Matt O'Brien has maintained a Neutral rating on Humacyte (NASDAQ:HUMA) but reduced the price target from $3.5 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 10:16 pm